Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC.
Wang J, Li X, Xue X, Ou Q, Wu X, Liang Y, Wang X, You M, Shao YW, Zhang Z, Zhang S.
Wang J, et al. Among authors: shao yw.
Int J Cancer. 2019 Jun 1;144(11):2677-2682. doi: 10.1002/ijc.31895. Epub 2018 Dec 16.
Int J Cancer. 2019.
PMID: 30255937
Free PMC article.